
About company
Allenex AB (publ), a life science company, develops, manufactures, markets, and sells products for transplantation of blood stem cells and organs worldwide. The company develops kits for genomic Human Leukocyte Antigens (HLA) typing used prior to hematopoietic stem cell/bone marrow transplantation and organ transplantation to match the donor and recipient; and XM-ONE, products and services for organ transplantation. Its research portfolio includes AB0 column for transplantations between people of different blood groups; and an AB0 diagnostic test that measures the occurrence of blood group antibodies. Allenex AB (publ) sells its products through sub-distributors primarily to laboratories active in transplantation diagnostics. The company was formerly known as LinkMed AB and changed its name to Allenex AB in June 2011. Allenex AB (publ) was founded in 1998 and is headquartered in Stockholm, Sweden.